These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15922837

  • 1. Synthesis and evaluation of double bond substituted combretastatins.
    Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT.
    Eur J Med Chem; 2005 Jun; 40(6):529-41. PubMed ID: 15922837
    [Abstract] [Full Text] [Related]

  • 2. Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
    Gaukroger K, Hadfield JA, Lawrence NJ, Nolan S, McGown AT.
    Org Biomol Chem; 2003 Sep 07; 1(17):3033-7. PubMed ID: 14518125
    [Abstract] [Full Text] [Related]

  • 3. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 07; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological activity of mustard derivatives of combretastatins.
    Coggiola B, Pagliai F, Allegrone G, Genazzani AA, Tron GC.
    Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3551-4. PubMed ID: 15963722
    [Abstract] [Full Text] [Related]

  • 5. New naphthylcombretastatins. Modifications on the ethylene bridge.
    Sánchez Maya AB, Pérez-Melero C, Salvador N, Peláez R, Caballero E, Medarde M.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2097-107. PubMed ID: 15727863
    [Abstract] [Full Text] [Related]

  • 6. Novel cyanocombretastatins as potent tubulin polymerisation inhibitors.
    Jalily PH, Hadfield JA, Hirst N, Rossington SB.
    Bioorg Med Chem Lett; 2012 Nov 01; 22(21):6731-4. PubMed ID: 23010271
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T, Busacca S, Beltrami L, Imovilli D, Pagliai F, Miglio G, Massarotti A, Verotta L, Tron GC, Sorba G, Genazzani AA.
    J Med Chem; 2006 Aug 24; 49(17):5372-6. PubMed ID: 16913727
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antimicrotubule activity of combretatropone derivatives.
    Janik ME, Bane SL.
    Bioorg Med Chem; 2002 Jun 15; 10(6):1895-903. PubMed ID: 11937347
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
    Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3417-20. PubMed ID: 17434303
    [Abstract] [Full Text] [Related]

  • 11. Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies.
    Burja B, Cimbora-Zovko T, Tomić S, Jelusić T, Kocevar M, Polanc S, Osmak M.
    Bioorg Med Chem; 2010 Apr 01; 18(7):2375-87. PubMed ID: 20338766
    [Abstract] [Full Text] [Related]

  • 12. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
    Theeramunkong S, Caldarelli A, Massarotti A, Aprile S, Caprioglio D, Zaninetti R, Teruggi A, Pirali T, Grosa G, Tron GC, Genazzani AA.
    J Med Chem; 2011 Jul 28; 54(14):4977-86. PubMed ID: 21696175
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological activity of fluorinated combretastatin analogues.
    Alloatti D, Giannini G, Cabri W, Lustrati I, Marzi M, Ciacci A, Gallo G, Tinti MO, Marcellini M, Riccioni T, Guglielmi MB, Carminati P, Pisano C.
    J Med Chem; 2008 May 08; 51(9):2708-21. PubMed ID: 18396857
    [Abstract] [Full Text] [Related]

  • 14. Discovery of azaisoerianin derivatives as potential antitumors agents.
    Soussi MA, Provot O, Bernadat G, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Messaoudi S, Alami M.
    Eur J Med Chem; 2014 May 06; 78():178-89. PubMed ID: 24681982
    [Abstract] [Full Text] [Related]

  • 15. p,p-Dihydroxydihydrostilbenophanes related to antimitotic combretastatins. Conformational analysis and its relationship to tubulin inhibition.
    Álvarez R, López V, Mateo C, Medarde M, Peláez R.
    J Org Chem; 2014 Aug 01; 79(15):6840-57. PubMed ID: 24966024
    [Abstract] [Full Text] [Related]

  • 16. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
    Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ.
    Bioorg Med Chem; 2009 Nov 15; 17(22):7698-710. PubMed ID: 19837593
    [Abstract] [Full Text] [Related]

  • 17. Conformationally restricted macrocyclic analogues of combretastatins.
    Mateo C, Alvarez R, Pérez-Melero C, Peláez R, Medarde M.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6316-20. PubMed ID: 17889536
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
    Sriram M, Hall JJ, Grohmann NC, Strecker TE, Wootton T, Franken A, Trawick ML, Pinney KG.
    Bioorg Med Chem; 2008 Sep 01; 16(17):8161-71. PubMed ID: 18722127
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
    Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG.
    Bioorg Med Chem; 2006 May 01; 14(9):3231-44. PubMed ID: 16442292
    [Abstract] [Full Text] [Related]

  • 20. Pharmaceutical design of antimitotic agents based on combretastatins.
    Hsieh HP, Liou JP, Mahindroo N.
    Curr Pharm Des; 2005 May 01; 11(13):1655-77. PubMed ID: 15892667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.